Treatment satisfaction significantly improves in patients with multiple sclerosis switching from interferon beta therapy to peginterferon beta-1a every 2 weeks.

Patient Prefer Adherence · 2018 · PMC6056153 · PMID 30050291

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Mean values showed a trend in improvement from baseline for patients in the SC IFN beta-1a or beta-1b group, but no changes were significantly different from baseline.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.